Revvity, Inc. (0KHE.L)
0KHE.L Stock Price Chart
Explore Revvity, Inc. interactive price chart. Choose custom timeframes to analyze 0KHE.L price movements and trends.
0KHE.L Company Profile
Discover essential business fundamentals and corporate details for Revvity, Inc. (0KHE.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
29 Jan 2018
Employees
11.00K
Website
https://www.perkinelmer.comCEO
Prahlad R. Singh
Description
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
0KHE.L Financial Timeline
Browse a chronological timeline of Revvity, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 29 Jan 2026
Upcoming earnings on 3 Nov 2025
Upcoming earnings on 28 Jul 2025
Revenue estimate is $711.26M.
Dividend declared on 18 Jul 2025
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend will be paid on 8 Aug 2025.
Earnings released on 28 Apr 2025
EPS came in at $0.35 falling short of the estimated $0.95 by -62.98%, while revenue for the quarter reached $664.76M, missing expectations by -6.48%.
Dividend declared on 17 Apr 2025
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 9 May 2025.
Earnings released on 31 Jan 2025
EPS came in at $1.42 surpassing the estimated $1.37 by +3.65%, while revenue for the quarter reached $729.58M, beating expectations by +9.53%.
Dividend declared on 17 Jan 2025
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 7 Feb 2025.
Earnings released on 4 Nov 2024
EPS came in at $0.76 falling short of the estimated $1.13 by -32.83%, while revenue for the quarter reached $684.05M, beating expectations by +0.65%.
Dividend declared on 18 Oct 2024
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 8 Nov 2024.
Earnings released on 29 Jul 2024
EPS came in at $0.45 falling short of the estimated $1.12 by -59.97%, while revenue for the quarter reached $691.69M, beating expectations by +0.20%.
Dividend declared on 19 Jul 2024
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 9 Aug 2024.
Earnings released on 29 Apr 2024
EPS came in at $0.22 falling short of the estimated $0.94 by -76.20%, while revenue for the quarter reached $649.92M, beating expectations by +0.41%.
Dividend declared on 18 Apr 2024
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 10 May 2024.
Earnings released on 5 Mar 2024
EPS came in at $0.83 falling short of the estimated $1.16 by -28.28%, while revenue for the quarter reached $695.90M, beating expectations by +2.77%.
Dividend declared on 18 Jan 2024
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 9 Feb 2024.
Earnings released on 30 Oct 2023
EPS came in at $0.08 falling short of the estimated $1.19 by -93.54%, while revenue for the quarter reached $670.74M, missing expectations by -3.55%.
Dividend declared on 19 Oct 2023
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 10 Nov 2023.
Earnings released on 1 Aug 2023
EPS came in at $0.28 falling short of the estimated $1.19 by -76.17%, while revenue for the quarter reached $709.07M, beating expectations by +0.10%.
Dividend declared on 20 Jul 2023
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 11 Aug 2023.
Earnings released on 11 May 2023
EPS came in at $4.50 surpassing the estimated $1.00 by +350.45%, while revenue for the quarter reached $674.87M, missing expectations by -0.59%.
Dividend declared on 20 Apr 2023
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 12 May 2023.
Earnings released on 14 Feb 2023
EPS came in at $1.09 falling short of the estimated $1.64 by -33.54%, while revenue for the quarter reached $741.21M, missing expectations by -27.96%.
Dividend declared on 19 Jan 2023
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 10 Feb 2023.
Dividend declared on 20 Oct 2022
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 11 Nov 2022.
Earnings released on 2 Oct 2022
EPS came in at $0.55 falling short of the estimated $1.44 by -61.87%, while revenue for the quarter reached $711.80M, missing expectations by -30.30%.
Dividend declared on 21 Jul 2022
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 12 Aug 2022.
Earnings released on 3 Jul 2022
EPS came in at $1.42 falling short of the estimated $2.01 by -29.35%, while revenue for the quarter reached $1.23B, beating expectations by +2.15%.
Dividend declared on 21 Apr 2022
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 13 May 2022.
Earnings released on 3 Apr 2022
EPS came in at $1.40 falling short of the estimated $2.12 by -33.96%, while revenue for the quarter reached $1.26B, beating expectations by +5.92%.
Dividend declared on 20 Jan 2022
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 11 Feb 2022.
Earnings released on 2 Jan 2022
EPS came in at $1.41, while revenue for the quarter reached $1.36B.
Dividend declared on 21 Oct 2021
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 12 Nov 2021.
Earnings released on 3 Oct 2021
EPS came in at $1.11 falling short of the estimated $2.25 by -50.67%, while revenue for the quarter reached $1.17B, missing expectations by -8.39%.
Dividend declared on 15 Jul 2021
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 6 Aug 2021.
Earnings released on 4 Jul 2021
EPS came in at $2.19, while revenue for the quarter reached $1.23B.
Dividend declared on 15 Apr 2021
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 7 May 2021.
Earnings released on 4 Apr 2021
EPS came in at $3.37, while revenue for the quarter reached $1.31B.
Dividend declared on 21 Jan 2021
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 12 Feb 2021.
Earnings released on 3 Jan 2021
EPS came in at $3.38, while revenue for the quarter reached $1.35B.
Dividend declared on 15 Oct 2020
A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 6 Nov 2020.
Earnings released on 4 Oct 2020
EPS came in at $1.57, while revenue for the quarter reached $964.03M.
0KHE.L Stock Performance
Access detailed 0KHE.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.